Clinical Trial Update: A Trial to Compare the Laser Treatment (SLT vs. ALT) in Glaucoma Patients [Phase 3]

View source ↗

Summary

This entry notes a Phase 3 trial comparing selective laser trabeculoplasty (SLT) with argon laser trabeculoplasty (ALT) in glaucoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Argon Laser Trabeculoplasty (ALT) (Argon Laser Trabeculoplasty)
• Selective laser trabeculoplasty (SLT)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Glaucoma | Phase 3 | Status: UNKNOWN